Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-361 | HER2amp | Luminal | MG-132 | Proteasome | Proteasome | 0.000853 | uM | 12379.17 | 0.9883 | 0.9598 | 0.5805 | |
MDA-MB-361 | HER2amp | Luminal | MG-132 | Proteasome | Proteasome | 0.000853 | uM | 12379.17 | 0.9883 | 0.9598 | 0.5805 | |
MDA-MB-361 | HER2amp | Luminal | MG-132 | Proteasome | Proteasome | 0.00427 | uM | 12379.17 | 1.0026 | 1.0089 | 0.5805 | |
MDA-MB-361 | HER2amp | Luminal | MG-132 | Proteasome | Proteasome | 0.00427 | uM | 12379.17 | 1.0026 | 1.0089 | 0.5805 | |
MDA-MB-361 | HER2amp | Luminal | MG-132 | Proteasome | Proteasome | 0.0213 | uM | 12379.17 | 0.9973 | 0.9905 | 0.5805 | |
MDA-MB-361 | HER2amp | Luminal | MG-132 | Proteasome | Proteasome | 0.0213 | uM | 12379.17 | 0.9973 | 0.9905 | 0.5805 | |
MDA-MB-361 | HER2amp | Luminal | MG-132 | Proteasome | Proteasome | 0.107 | uM | 12379.17 | 0.9781 | 0.9250 | 0.5805 | |
MDA-MB-361 | HER2amp | Luminal | MG-132 | Proteasome | Proteasome | 0.107 | uM | 12379.17 | 0.9781 | 0.9250 | 0.5805 | |
MDA-MB-361 | HER2amp | Luminal | MG-132 | Proteasome | Proteasome | 0.533 | uM | 12379.17 | 0.2904 | -0.7623 | 0.5805 | |
MDA-MB-361 | HER2amp | Luminal | MG-132 | Proteasome | Proteasome | 0.533 | uM | 12379.17 | 0.2904 | -0.7623 | 0.5805 | |
MDA-MB-361 | HER2amp | Luminal | MG-132 | Proteasome | Proteasome | 2.67 | uM | 12379.17 | 0.1063 | -0.9579 | 0.5805 | |
MDA-MB-361 | HER2amp | Luminal | MG-132 | Proteasome | Proteasome | 2.67 | uM | 12379.17 | 0.1063 | -0.9579 | 0.5805 | |
MDA-MB-361 | HER2amp | Luminal | MG-132 | Proteasome | Proteasome | 13.3 | uM | 12379.17 | 0.0230 | -0.9970 | 0.5805 | |
MDA-MB-361 | HER2amp | Luminal | MG-132 | Proteasome | Proteasome | 13.3 | uM | 12379.17 | 0.0230 | -0.9970 | 0.5805 | |
MDA-MB-361 | HER2amp | Luminal | MG-132 | Proteasome | Proteasome | 66.7 | uM | 12379.17 | 0.0224 | -0.9971 | 0.5805 | |
MDA-MB-361 | HER2amp | Luminal | MG-132 | Proteasome | Proteasome | 66.7 | uM | 12379.17 | 0.0224 | -0.9971 | 0.5805 | |
MDA-MB-415 | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 0.000171 | uM | 10938.145 | 0.9126 | 0.8414 | 1.1073 | |
MDA-MB-415 | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 0.000171 | uM | 10938.145 | 0.9126 | 0.8414 | 1.1073 | |
MDA-MB-415 | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 0.000853 | uM | 10938.145 | 0.8212 | 0.6741 | 1.1073 | |
MDA-MB-415 | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 0.000853 | uM | 10938.145 | 0.8212 | 0.6741 | 1.1073 | |
MDA-MB-415 | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 0.00427 | uM | 10938.145 | 0.8438 | 0.7157 | 1.1073 | |
MDA-MB-415 | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 0.00427 | uM | 10938.145 | 0.8438 | 0.7157 | 1.1073 | |
MDA-MB-415 | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 0.0213 | uM | 10938.145 | 0.7964 | 0.6283 | 1.1073 | |
MDA-MB-415 | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 0.0213 | uM | 10938.145 | 0.7964 | 0.6283 | 1.1073 | |
MDA-MB-415 | HR+ | Luminal | MG-132 | Proteasome | Proteasome | 0.107 | uM | 10938.145 | 0.6049 | 0.2703 | 1.1073 |